Liu et al. identified a subtype diagnostic signature that is composed of ELOA and SCAF4 in esophageal cancer, and two molecular subtypes of esophageal cancer with different prognoses were defined based on the nuclear expression of SCAF4 and ELOA.7 This evidence concerns the gene ELOA and esophageal cancer.